Arrowhead Breaks Ground on New Manufacturing Facility with Wisconsin Governor Tony Evers and Announces Receipt of Incentives

Date Published05/09/2022
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Arrowhead Pharmaceuticals, Inc.
Parent companyArrowhead Pharmaceuticals, Inc.
Type of work Manufacturing
Reshoring category:Reshoring
What product(s) and/or service(s) were outsourced domestically?Manufacturing
Year reshoring announced:2022
Year reshoring implemented or to be implemented:2024
Domestically, the work will be done:In-house
City reshored to:Verona
State(s) reshored to:WI
If relevant, work nearshored to:-
Product(s) reshoredpharmaceuticals
What domestic positive factors made reshoring more attractive?Government Incentives, $2.5 M, refundable Wisconsin state income tax cred
Government Incentive dollar amount:$16 million in tax increment
Find Reshoring Articles